Common gout drug tested for a different type of painful arthritis
NCT ID NCT06855433
Summary
This study is testing if a daily pill called colchicine can reduce inflammation and joint pain in people with calcium pyrophosphate deposition (CPPD) disease, a form of arthritis caused by calcium crystals in the joints. Researchers will compare colchicine to a placebo (sugar pill) in 150 participants over six months. The main goals are to see if the drug lowers a specific blood marker of inflammation and improves patients' pain scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CPPD - CALCIUM PYROPHOSPHATE DEPOSITION DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.